Hengrui Medicine will hold a shareholders meeting on September 8

Every time AI News, Hengrui Pharmaceutical (SH 600276, closing price: 35.9 yuan) issued an announcement on August 19 that at 14:00 on September 8, 2022, the company will hold the first temporary temporary temporary in 2022 in the company's conference room in 2022 Shareholders' meeting. The shareholders' meeting will review the motion such as the "Proposal on and the Abstract". The shareholders registered after receiving the market on September 1, 2022 can participate in the vote on the spot, or exercise voting rights through the exchange voting system.

From January to December 2021, Hengrui Pharmaceutical's operating income composed of 99.52%of the pharmaceutical manufacturing industry.

The chairman of Hengrui Pharmaceutical is Sun Piao, male, 64 years old, and his academic background is a doctorate. The general manager is Dai Hongbin, male, 46 years old, and his academic background is a master's degree.

As of press time, Hengrui Pharmaceutical's market value was 229 billion yuan.

Daeda1997 "Single Stock Trends" reminder:

1. Hengrui Pharmaceutical's shareholding in northern direction in the past 30 days increased by 8.8219 million shares, accounting for 0.14%of the proportion of circulating shares;

2. In the past 30 days, there was no mechanism to investigate Hengrui Pharmaceutical.

For more stock trend information, please search for the WeChat public account "Daida", reply "Query", and receive free query permissions!

Every headline (NBDTOUTIAO) -This position is too sought after, "annual salary is not a dream"! The peers were admired: "Join if you can't fight"

(Reporter Zhang Xiwei)

Disclaimer: The content and data of this article are for reference only, and do not constitute investment suggestions. Please verify before use. Based on this, the risk is on its own.

Daily Economic News

- END -